Artemis Hospitals observed National Brain Week to disseminate Awareness on Neurological Disorders
Gurugram: Artemis Hospitals, Gurugram, in association with the Indian Academy of Neurology, organized a week-long awareness campaign ‘My Health My Responsibility’ to commemorate National Brain Week from 18th December 2020 to…
AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin
The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed Covid-19 vaccine candidate ‘Covaxin’ for which…
Aurobindo Pharma signs pact with Covaxx for Covid-19 vaccine
Hyderabad: Aurobindo Pharma Ltd and Covaxx, a US-based company, have entered into an exclusive license agreement to develop, commercialise and manufacture UB-612, the first Multitope Peptide-based vaccine to fight Covid-19, for India and UNICEF. According…
Reproductive Technologies-The Harbinger of Life
Dr.Gautam Allahbadia’s Gift Looking at our own reflection might be disconcerting for some of us. However, watching our offspring grow day by day will always be the best feeling that…
Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe
NEW DELHI: Glenmark Pharmaceuticals on Wednesday said its subsidiary has inked a licensing pact with Menarini Group for commercialising its nasal spray Ryaltris across 33 countries in Europe, including the Balkan region. Glenmark Specialty, a Switzerland-based unit…
Cipla Seeks Approval To Modify Remdesivir Composition To Reduce Renal Toxicity
Mumbai : The Mumbai headquartered pharma giant Cipla has sought approval from the subject expert committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) to modify Covid-19 drug remdesivir’s composition…
Haryana Set To Become Hub Of Medical Devices
Chennai : Haryana, the erstwhile popular hub of pharmaceutical formulations in the northern part of the country, is now turning out to be the centre of the medical devices industry to…
India likely to approve AstraZeneca vaccine by next week: Sources
NEW DELHI: India is likely to approve Oxford/AstraZeneca’s coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge…
India’s Atmanirbhar Capabilities in Medical Technology Knocking
New Delhi: Could indigenous manufacturing of medical devices be India’s strong suits as it is in drug manufacturing? Given the Atmanirbhar (self reliant) capabilities shown by Indian medical device industry,…
Building Immunity: Ensuring Holistic Health and Wellness in Winter
New Delhi: Starting from winter 2019 to winter 2020, the world at large has been reeling under the unprecedented health crisis, which the COVID-19 has brought in. This winter has…
